| One active site, two modes of reduction correlate the mechanism of leishmania pteridine reductase w… | | homo-4-mer | 5-288 | 99.62 | 4×NDP; 4×MTX; 6×EDO; |
|
| The crystal structure of Leishmania major Pteridine Reductase 1 in complex with substrate folic acid | | homo-4-mer | 5-288 | 99.62 | 4×FOL; 4×NDP; 2×PGE; 4×GOL; 1×PEG; |
|
| Leishmania major Pteridine reductase 1 (PTR1) in complex with compound 3 | | homo-4-mer | 5-288 | 99.62 | 4×6J6; 4×NDP; 6×GOL; 4×ACT; 1×PGE; 5×EDO; |
|
| Leishmania major pteridine reductase 1 (LmPTR1) in complex with inhibitor 4 (NMT-C0026) | | homo-4-mer | 5-288 | 99.62 | 4×NDP; 4×KMK; |
|
| Pteridine reductase 1 from Leishmania major complexed with NADP+ and dihydrobiopterin | | homo-4-mer | 5-288 | 99.63 | 4×NAP; 4×HBI; 4×EDO; |
|
| Leishmania major Pteridine reductase 1 (PTR1) in complex with compound 1 | | homo-4-mer | 5-288 | 99.61 | 2×6QT; 4×NDP; 1×GOL; 1×ACT; 1×PEG; 1×PGE; 3×EDO; |
|
| Selective screening and design to identify inhibitors of leishmania major pteridine reductase 1 | | homo-4-mer | 5-288 | 99.63 | 4×NAP; 4×DVP; |
|
| Leishmania major pteridine reductase 1 in complex with NADP and biopterin | | homo-4-mer | 5-288 | 99.62 | 4×NAP; 4×HBI; 5×EDO; |
|
| Leishmania major pteridine reductase 1 in complex with NADP and tetrahydrobiopterin | | homo-4-mer | 5-288 | 99.62 | 4×NAP; 4×H4B; 6×EDO; |
|
| Leishmania major pteridine reductase 1 in complex with NADP and trimethoprim | | homo-4-mer | 5-288 | 99.62 | 4×NDP; 2×TOP; |
|
| Leishmania major pteridine reductase 1 in complex with NADPH | | homo-4-mer | 5-288 | 99.62 | 4×NDP; 6×EDO; |
|
| Inhibition of Leishmania major pteridine reductase (PTR1) by 2,4,6-triaminoquinazoline; structure o… | | homo-4-mer | 5-288 | 99.64 | 4×NAP; 5×TAQ; |
|
| Structure of Pteridine Reductase from Leishmania major complexed with a ligand | | homo-4-mer | 5-288 | 99.62 | 2×IOD; 4×NAP; 4×FE1; |
|
| Leishmania major pteridine reductase 1 in complex with NADP and CB3717 | | homo-4-mer | 6-288 | 99.62 | 4×NDP; 4×CB3; 6×EDO; |
|